Cargando…
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
Three patients, each of whom had required intensive open-ended antimicrobial therapy for control of the symptoms of chronic relapsing neurological Lyme disease and relapsing babesiosis, were able to discontinue treatment and remain clinically well for periods of observation of 6–23 months following...
Autor principal: | Liegner, Kenneth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627205/ https://www.ncbi.nlm.nih.gov/pubmed/31151194 http://dx.doi.org/10.3390/antibiotics8020072 |
Ejemplares similares
-
“Repurposing” Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice
por: Gao, Jiachen, et al.
Publicado: (2020) -
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
por: Potula, Hari-Hara S. K., et al.
Publicado: (2020) -
Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada
por: Allehebi, Ziyad O., et al.
Publicado: (2022) -
A Case of Tick Bite Induced Babesiosis With Lyme Disease
por: Bhesania, Siddharth, et al.
Publicado: (2021) -
Potential Patient-Reported Toxicities With Disulfiram Treatment in Late Disseminated Lyme Disease
por: Trautmann, Alain, et al.
Publicado: (2020)